These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 2444504)

  • 1. Severity of coronary artery disease and basal fibrinolysis.
    Small M; Lowe GD; Beattie JM; Hutton I; Lorimer AR; Forbes CD
    Haemostasis; 1987; 17(5):305-11. PubMed ID: 2444504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of coagulation-fibrinolysis system and platelet function in patients with vertigo.
    Noda Y; Nakamura M; Sasaki M; Kosugi T
    Auris Nasus Larynx; 1986; 13 Suppl 1():S75-9. PubMed ID: 2429647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous testosterone, fibrinolysis, and coronary heart disease risk in hyperlipidemic men.
    Glueck CJ; Glueck HI; Stroop D; Speirs J; Hamer T; Tracy T
    J Lab Clin Med; 1993 Oct; 122(4):412-20. PubMed ID: 8228555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of the enzyme preparation longolytin on fibrinolysis in animals].
    Serebriakova TN; Andreenko GV; Tsymanovich SG; Maksimova RA; Sharkova TS
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (2):66-71. PubMed ID: 3157406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early local and systemic fibrinolytic response to high energy missile trauma.
    Almskog B; Risberg B; Teger-Nilsson AC; Seeman T
    Acta Chir Scand Suppl; 1982; 508():327-36. PubMed ID: 6177148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal and maternal fibrinolysis: activation at time of birth.
    Suarez CR; Walenga J; Mangogna LC; Fareed J
    Am J Hematol; 1985 Aug; 19(4):365-72. PubMed ID: 2411128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fibrinolytic response to ancrod therapy: characterization of fibrinogen and fibrin degradation products.
    Prentice CR; Hampton KK; Grant PJ; Nelson SR; Nieuwenhuizen W; Gaffney PJ
    Br J Haematol; 1993 Feb; 83(2):276-81. PubMed ID: 8457476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On fibrinolysis in diabetes mellitus.
    Almér LO; Nilsson IM
    Acta Med Scand; 1975; 198(1-2):101-6. PubMed ID: 52286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction.
    Van de Werf F; Ludbrook PA; Bergmann SR; Tiefenbrunn AJ; Fox KA; de Geest H; Verstraete M; Collen D; Sobel BE
    N Engl J Med; 1984 Mar; 310(10):609-13. PubMed ID: 6537987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced fibrinolytic activity in coronary heart disease in basal conditions and after exercise.
    Estellés A; Tormo G; Aznar J; España F; Tormo V
    Thromb Res; 1985 Nov; 40(3):373-83. PubMed ID: 4082114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional fibrinolytic study in coronary artery disease.
    Patrassi GM; Bisetti P; Chioin R; Procidano M; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(2):307-12. PubMed ID: 6179833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases.
    Collatos C; Barton MH; Prasse KW; Moore JN
    J Am Vet Med Assoc; 1995 Aug; 207(4):465-70. PubMed ID: 7591947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The study of local fibrinolysis in abortion.
    Ikeuchi M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jul; 37(7):1215-23. PubMed ID: 2411832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism.
    Chadarevian R; Bruckert E; Leenhardt L; Giral P; Ankri A; Turpin G
    J Clin Endocrinol Metab; 2001 Feb; 86(2):732-7. PubMed ID: 11158038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of smoking on the haemostatic mechanism in pregnancy.
    Condie RG; Pirani BB
    Acta Obstet Gynecol Scand; 1977; 56(1):5-8. PubMed ID: 65896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathogenesis of accelerated fibrinolysis in hepatosplenic schistosomiasis.
    Omran SA; Madkour BA; Essawy FM; Toima SM; el Kaliouby AH; Shams el Din AA
    Blood Coagul Fibrinolysis; 1992 Dec; 3(6):819-22. PubMed ID: 1489902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting coagulation: fibrinolysis in chronic subdural fluid collections.
    Weir B; Gordon P
    J Neurosurg; 1983 Feb; 58(2):242-5. PubMed ID: 6848682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fibrinolytic system in patients with myocardial infarction and other coronary disease risk factors].
    Moreno JA; Gálvez MM; Cornudella R; Angós JA; Romero MS; Gutiérrez M
    Sangre (Barc); 1994 Apr; 39(2):111-6. PubMed ID: 8059288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteolysis of fibrinogen in healthy volunteers following major and minor vivo plasminogen activation.
    Prowse CV; Dawes J; Lane DA; Ireland H; Knight I
    Thromb Res; 1982 Jul; 27(1):91-7. PubMed ID: 6750837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.